Skip to Content

Access to medicines 

As a result of our work together with the CF community, every province and territory now funds the transformational CF drug Trikafta for eligible people in Canada aged six and older who have at least one copy of the most common cystic fibrosis mutation in Canada. Some jurisdictions are reimbursing for those ages 2 and over, and we are hopeful more will come on board soon. 

But access to drugs like Trikafta is still not equitable across the country.  There are still significant access barriers faced by many in our community and we continue to use our strength in advocacy to fight for fair and affordable access to all needed therapies for CF.  

""

Become an advocate 

Do you want to join the fight for access to life-saving cystic fibrosis treatments and other vital services in Canada? As an advocate, you will learn about the issues facing Canadians with CF, be a part of a vibrant network of people doing great work and have access to toolkits, expert training and resources to raise our collective voices.